Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
about
Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.Dexmedetomidine Postconditioning Reduces Brain Injury after Brain Hypoxia-Ischemia in Neonatal Rats.Dexmedetomidine post-treatment induces neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhageDexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats.Critical Evaluation of the Lund Concept for Treatment of Severe Traumatic Head Injury, 25 Years after Its IntroductionOrganotypic Hippocampal Slices as Models for Stroke and Traumatic Brain InjuryStudy of cell apoptosis in the hippocampus and thalamencephalon in a ventricular fluid impact modelEffects of COX inhibition and LPS on formalin induced pain in the infant ratα2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.Alpha-adrenoceptor modulation in central nervous system trauma: pain, spasms, and paralysis--an unlucky triad.Argon attenuates the emergence of secondary injury after traumatic brain injury within a 2-hour incubation period compared to desflurane: an in vitro study.A pilot study of dexmedetomidine sedation and caudal anesthesia for inguinal hernia repair in infants.Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase.The effects of 2 µg and 4 µg doses of dexmedetomidine in combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its postoperative analgesic characteristics.Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice.Desflurane impairs outcome of organotypic hippocampal slices in an in vitro model of traumatic brain injuryNon-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.Low dose dexmedetomidine for the prophylaxis of perioperative ICU delirium-how much evidence is enough?Dexmedetomidine: what next?Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.Neuroprotection of dexmedetomidine against propofol-induced neuroapoptosis partly mediated by PI3K/Akt pathway in hippocampal neurons of fetal rat*.MiR-29b expression is associated with a dexmedetomidine-mediated protective effect against oxygen-glucose deprivation-induced injury to SK-N-SH cells in vitro.Dexmedetomidine protects against glucocorticoid induced progenitor cell apoptosis in neonatal mouse cerebellum.Preventive effects of dexmedetomidine on the development of cognitive dysfunction following systemic inflammation in aged rats.Delirium in the Cardiac Intensive Care Unit.Dexmedetomidine increases acetylation level of histone through ERK1/2 pathway in dopamine neuron.Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms.Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury.Inflammatory Response in Patients under Coronary Artery Bypass Grafting Surgery and Clinical Implications: A Review of the Relevance of Dexmedetomidine Use
P2860
Q27307725-129AB45B-075F-4B6F-AA65-EEDB4F0F34BFQ30277236-E96A1735-0273-4CA5-9674-F68C435E1EE1Q30277368-C78F20C2-222E-4781-AE8F-92C3BF9596E1Q30413769-2F117F3E-6BAD-494F-AE0F-B7C00FD672EEQ33867530-55403EC3-A6D5-4676-A0C4-580ACCC60137Q34487468-187ED841-B981-453D-B6CF-99A1F82D598FQ35047396-E4CDB06D-4CEC-42A2-BAA9-7BB76B9F5CDBQ35185830-47719FB0-D16D-43C6-8C27-EF7ACF73ED54Q37636573-2D7ADB4E-23A0-4B8B-A48D-E1DF85323CD1Q38302539-72E09FEE-2212-41E6-87DD-215AA1BE9358Q38661248-2879F8B7-476A-4071-A609-4EA8CFF50584Q38803231-5E4A5176-3E31-405E-B201-8D504CEB9F7DQ38969654-C0C94E56-FA54-4899-93A2-16AF47F5178BQ39811485-ED77ACAE-5C7A-494F-A081-8F2761409CC9Q40341409-ED545A8E-1249-4F77-8CD7-4F33EB042863Q41543725-E88E7D22-3CAC-4AFA-9CA1-B1B7325887FEQ42328273-ADCD6FCC-B921-4CD1-93AB-A25DE0AAB44EQ42344263-D2071A1D-9C64-4534-871E-9BE980CE5760Q42441373-0CB19C5A-1741-43B6-9984-7ED0792F78C0Q43106827-58A6A769-8EDD-4F8F-91AB-5E1B5F3CE2E3Q47134892-D1818E3E-0A18-48FB-8291-262066138B93Q47395735-C7C73AED-0491-44D4-AD79-F5E32CB6B226Q48332873-8EA68146-4F41-486F-8CCB-5787B10E4CCEQ48479593-B5575BA8-B2AE-4F46-8D2A-B4BA249ECACFQ49913763-5AE426D7-CE7D-4679-A00F-A1775AB22A1FQ51687312-AA9C0E97-FFC7-4724-9D67-1E343A7AE87DQ55344710-A135474E-3F85-49AB-917B-BC31CFB83841Q55375064-BC71BA2E-3B2B-45BE-B0D3-0BC516EE37D7Q55387407-6B74099B-EA4C-44E3-A144-B8035E63B74DQ59049799-2DC8A818-471F-45B6-A13D-4BE92C9CA794
P2860
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
@en
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
@nl
type
label
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
@en
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
@nl
prefLabel
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
@en
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury.
@nl
P2093
P2860
P356
P1433
P1476
Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury
@en
P2093
Astrid V Fahlenkamp
Georg Eberhardt
Joachim Weis
Marc Schoeler
Philip D Loetscher
Rolf Rossaint
P2860
P2888
P356
10.1186/1471-2377-12-20
P577
2012-04-11T00:00:00Z
P5875
P6179
1026948775